Human glandular kallikrein 2 (hK2) has been reported to increase the precision of PSA-based prediction in patients with PSA levels below the standard cut-off thresholds for biopsy, and might be useful in determining clinically insignificant PCa. Here, HK2 is linked to posterior cortical atrophy.